second COX-2 inhibitor, Vioxx (rofecoxib)

The FDA is close to approving a second COX-2 inhibitor, Vioxx (rofecoxib)...from Merck.

Vioxx will be approved for osteoarthritis AND acute, menstrual, post-surgical, etc.

Celebrex is approved only for osteo- and rheumatoid arthritis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote